Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in Working CapitalChange in Working CapitalDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsSales of Property, Plant and EquipmentSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Asset Writedowns and Impairment (2016 - 2025)

Sanofi's Asset Writedowns and Impairment history spans 15 years, with the latest figure at -$2.6 billion for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment fell 456.07% to -$2.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was -$3.1 billion, a 1064.66% decrease, with the full-year FY2025 number at -$2.6 billion, down 456.07% from a year prior.
  • Asset Writedowns and Impairment hit -$2.6 billion in Q4 2025 for Sanofi, down from -$266.5 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for SNY hit a ceiling of $964.0 million in Q4 2023 and a floor of -$2.6 billion in Q4 2025.
  • Historically, Asset Writedowns and Impairment has averaged -$336.2 million across 5 years, with a median of -$65.4 million in 2022.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 135500.8% in 2022 and later skyrocketed 1266.96% in 2024.
  • Tracing SNY's Asset Writedowns and Impairment over 5 years: stood at -$219.6 million in 2021, then tumbled by 888.0% to -$2.2 billion in 2022, then skyrocketed by 144.42% to $964.0 million in 2023, then tumbled by 148.66% to -$469.1 million in 2024, then crashed by 456.07% to -$2.6 billion in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for SNY at -$2.6 billion in Q4 2025, -$266.5 million in Q3 2025, and -$209.4 million in Q2 2025.